These independent CME/CE activities are supported by educational grants from

AbbVie Inc.



Certificate Program Banner Goes Here
  1. Course List
Chair
Bruce D. Cheson, MD, FACP, FAAAS
  • Professor of Medicine
  • Head of Hematology and Deputy Chief
  • Division of Hematology-Oncology
  • Georgetown University Hospital
  • Lombardi Comprehensive Cancer Center
  • Washington, DC

  • Contributing Editor
    Anthony R. Mato, MD, MSCE

    Lindsey E. Roeker, MD, MSCE

    Faculty
    Susan M. O'Brien, MD, MA, BA
  • Associate Director of Clinical Sciences
  • Chao Family Comprehensive Cancer Center
  • University of California, Irvine
  • Orange, California

  • William G. Wierda, MD, PhD
  • Professor and D.B. Lane Cancer Research Distinguished Professor
  • Section Chief, Chronic Lymphocytic Leukemia
  • Center Medical Director
  • Department of Leukemia, Division of Cancer Medicine
  • Executive Medical Director
  • The University of Texas MD Anderson Cancer Center
  • Houston, Texas
  • Disclosure Information
    Bruce D. Cheson, MD, FACP, FAAAS   has received consulting fees from AbbVie, Inc., Acerta Pharma, Celgene Corporation, Hoffman-La Roche Ltd/Genentech, and TG Therapeutics, Inc.

    Anthony R. Mato, MD, MSCE   Anthony R. Mato, MD, MSCE, has received consulting fees from AbbVie, Inc., Janssen Pharmaceuticals, and Pharmacyclics Inc; and has contracted research from Celgene Corporation and Pharmacyclics, Inc.

    Lindsey E. Roeker, MD, MSCE   Lindsey E. Roeker, MD, has disclosed no relevant relationships.

    Susan M. O'Brien, MD, MA, BA   has received consulting fees from AbbVie, Inc., Alexion Pharmaceuticals, Inc, Amgen Inc., Aptose Biosciences Inc., Astellas Pharma, Inc, Celgene, Gilead Sciences, Inc., GlaxoSmithKline, Janssen Oncology, Pfizer Inc, Pharmacyclics Inc, Sunesis Pharmaceuticals Inc, TG Therapeutics, Inc., and Vanlam Group LLC; and has contracted research for Acerta Pharma, Gilead Sciences, Inc., Kite Pharma Inc., Pfizer Inc, Regeneron Pharmaceuticals, Pharmacyclics Inc, Sunesis Pharmaceuticals Inc, and TG Therapeutics, Inc.

    William G. Wierda, MD, PhD   has conducted contracted research for AbbVie, Inc., Acerta Pharma, Cyclacel Pharmaceuticals, Inc, Genentech, Gilead Sciences, Inc., GlaxoSmithKline/Novartis, Juno Therapeutics, Karyopharm Therapeutics, Kite Pharma Inc., miRagen Therapeutics, Inc, Oncternal Therapeutics, Pharmacyclics, Inc, and Sunesis Pharmaceuticals, Inc.